Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRNA7 | P36544 | 5/20 | 0.61 |
| ▸ | NTMT1 | Q9BV86 | 1/20 | 0.42 |
| ▸ | IL1B | P01584 | 1/20 | 0.39 |
| ▸ | NLRP3 | Q96P20 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | CHRM2 | P08172 | 3/20 | 0.37 |
| ▸ | CHRM1 | P11229 | 3/20 | 0.37 |
| ▸ | CHRM3 | P20309 | 2/20 | 0.37 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.37 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.37 |
| ▸ | SCD | O00767 | 1/20 | 0.37 |
| ▸ | CHRNB2 | P17787 | 3/20 | 0.36 |
| ▸ | CHRNB4 | P30926 | 3/20 | 0.36 |
| ▸ | CHRNA3 | P32297 | 3/20 | 0.36 |
| ▸ | CHRNA4 | P43681 | 3/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3840349 | 1.00 | CHRNA7 (0.61) | CHRNA7NTMT1IL1BNLRP3LMNA | |
| SCHEMBL3840489 | 0.86 | CHRNA7 (0.65) | CHRNA7NTMT1CHRM2CHRM1CHRM3 | |
| SCHEMBL1686042 | 0.86 | CHRNA7 (0.65) | CHRNA7NTMT1CHRM2CHRM1CHRM3 | |
| SCHEMBL1146350 | 0.86 | CHRNA7 (0.47) | CHRNA7NTMT1IL1BNLRP3LMNA | |
| SCHEMBL3843478 | 0.86 | CHRNA7 (0.60) | CHRNA7IL1BNLRP3LMNACHRM2 | |
| SCHEMBL1146351 | 0.86 | CHRNA7 (0.47) | CHRNA7NTMT1IL1BNLRP3LMNA | |
| SCHEMBL3843473 | 0.86 | CHRNA7 (0.60) | CHRNA7IL1BNLRP3LMNACHRM2 | |
| SCHEMBL1542809 | 0.84 | CHRNA7 (0.65) | CHRNA7NTMT1CHRM2CHRM1CHRM3 | |
| SCHEMBL5421431 | 0.84 | CHRNA7 (0.65) | CHRNA7CHRM2CHRM1CHRM3CHRM4 | |
| SCHEMBL3840206 | 0.84 | CHRNA7 (0.65) | CHRNA7NTMT1CHRM2CHRM1CHRM3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8236803-B2 | Aza-bicycloalkyl ethers and their use as alpha7-nAChR agonists | NOVARTIS AG (CH) | 2012-08-07 | — | — | US | claimed |
| EP-1537104-B1 | AZA-BICYCLOALKYL ETHERS AND THEIR USE AS ALPHA7-NACHR AGONISTS | NOVARTIS AG (CH) | 2009-11-11 | — | — | EP | claimed |
| EP-1537104-B1 | AZA-BICYCLOALKYL ETHERS AND THEIR USE AS ALPHA7-NACHR AGONISTS | NOVARTIS AG (CH) | 2009-11-11 | — | — | EP | disclosed |